Full-Time

Senior Scientist 1

Mass Spec

Updated on 8/3/2026

Deadline 4/14/27
Alcami

Alcami

51-200 employees

Pharmaceutical and biologics CDMO services

No salary listed

Wilmington, NC, USA

In Person

100% on-site; first-shift schedule is Monday–Friday, 8:30 a.m.–5:30 p.m.

Category
Lab & Research (1)
Required Skills
Microsoft Office
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Alcami

See people who can refer or advise you

Requirements
  • A bachelor's degree in Chemistry with 8+ years of experience, a master's degree with 4+ years of experience, or a Ph.D. with 2+ years of experience is required.
  • At least 2 years of experience in current good manufacturing practices in a pharmaceutical or regulated environment is required.
  • Excellent verbal and written communication and documentation skills are required.
  • Excellent detail orientation and organizational skills are required.
  • Excellent problem-solving and basic troubleshooting ability are required.
  • Excellent knowledge of laboratory equipment and safety is required.
  • Expert knowledge of laboratory documentation is required.
  • Ability to develop and implement new methods and processes is required.
  • Mass spectrometry skills, including gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry, triple quadrupole, and QTOF, with quantitative and qualitative work experience are required.
  • Ability to plan and manage multiple tasks for timely achievement of results is required.
  • Working knowledge of current good manufacturing practices in a pharmaceutical or regulated environment is required.
  • Proficiency with Microsoft Office, including Word, Excel, and PowerPoint, is required.
  • The employee must regularly lift or move up to 10 pounds, frequently lift or move up to 25 pounds, and occasionally lift or move up to 50 pounds.
  • The employee must wear appropriate personal protective equipment for specific job duties.
  • The employee must safely handle potent compounds.
Responsibilities
  • Perform routine and non-routine analytical testing supporting pharmaceutical product development or manufacturing.
  • Develop analytical methodologies using high-performance liquid chromatography, liquid chromatography/mass spectrometry, and gas chromatography/mass spectrometry.
  • Perform quantitative and qualitative mass spectrometry using triple quadrupole and QTOF systems.
  • Perform current good manufacturing practice review of solutions and chromatography.
  • Develop and validate methods, test procedures, protocols, and reports.
  • Apply the theoretical basis of methods and experiments.
  • Maintain knowledge of instrumentation, equipment, and scientific methodologies needed for assigned tasks.
  • Analyze information for technical correctness and accuracy.
  • Evaluate and interpret data.
  • Solve problems of diverse scope to achieve results.
  • Interact with clients and participate in regulatory agency or client audits.
  • Lead investigations and root cause analysis.
  • Drive initiatives outside the standard work function.
  • Maintain a safe, clean, organized, and hazard-free work environment.
  • Complete work and comply with current good manufacturing practice and other required company training.
  • Perform other assigned duties.
Desired Qualifications
  • Experience in a contract development and manufacturing organization is preferred.

Alcami is a contract development and manufacturing organization supporting pharmaceutical and biologics companies from early development through commercial production. Services span drug product manufacturing (sterile fill-finish and oral solid dose), analytical and microbiology lab testing, and cGMP storage with validation and environmental monitoring. What sets Alcami apart is its integrated, end-to-end capabilities across the development lifecycle. The goal is to help pharma and biotech partners deliver safe, high-quality therapies to patients.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Pepperell, Massachusetts

Founded

1984

Get referred to Alcami

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Leadership continuity can reassure CDMO clients during the 2025 transition.
  • Walsh's prior CEO experience should speed decisions on operations and customer escalations.
  • Facilities expansion and supply-chain realignment create upside if capacity ramps successfully.

What critics are saying

  • CEO turnover signals governance instability and can unsettle pharma customers.
  • Walsh's outside chair roles create attention-allocation risk across Alcami priorities.
  • Capacity ramp execution failures can cause delayed batches, missed timelines, and revenue slippage.

What makes Alcami unique

  • Patrick Walsh returns as interim CEO after two prior Alcami CEO tenures.
  • Alcami emphasized operational continuity and a client-centric approach during the transition.
  • A named executive bench supports execution across operations, finance, technology, HR, and strategy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

PR Newswire
Jan 13th, 2025
Alcami Announces Ceo Transition

Long time industry leader, Chairman of the Board Patrick Walsh replaces CEO Bill Humphries DURHAM, N.C., Jan. 13, 2025 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the resignation of Bill Humphries. Alcami's Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from a proven industry veteran

PR Newswire
Jul 23rd, 2024
Alcami Unveils New Conditions And Services At State-Of-The-Art Pharma Storage Facility In Garner

"Alcami's new facility is well positioned to fill previously unmet market demand," said Laurent Boer, President, Alcami Pharma Storage and Services. "The pipeline of complex medicines – exactly the type of ground-breaking products that life science companies in RTP work on – is only increasing. The biopharmaceutical materials and products in these drugs require very specific warehouse conditions that this new facility provides. But what truly sets us apart as a CDMO is our ability to offer a comprehensive pharma storage network paired with seamless access to our integrated laboratory and manufacturing services. From development to delivery, Alcami has the capabilities to care for and secure product within our own network, reducing risk and streamlining efficiency."After opening in January with controlled/ambient storage, the facility can now accept shipments for an extensive range of storage conditions, including stability chamber storage, refrigerated storage, freezer, ultra-low freezer, and cryogenic storage (LN2) as well as custom conditions. In addition, the site now offers a full suite of materials management and support services that facilitate the full product development, storage, and commercialization journey, including onsite aliquoting/sampling in grade C sampling booths, refrigerated transport, labeling, cycle counting/inventory management, custom kitting, and reference standards management.The new central North Carolina facility adjacent to the Research Triangle Park expands Alcami's high-quality, secure GMP storage network to six U.S

Contract Pharma
Dec 15th, 2021
alcami acquires Masy Systems Inc.

Alcami Corp., a pharmaceutical and biotech contract development and manufacturing organization ( CDMO ), has completed the acquisition of Masy Systems Inc., a provider of cGMP biostorage and pharma support services.

PR Newswire
Dec 15th, 2021
AAIPharma Services Corp. acquired Masy Systems Inc. on Dec 15th 21'.

Alcami Corporation, a leading pharmaceutical and biotech contract development and manufacturing organization (CDMO), announced today it has completed the acquisition of Masy Systems Inc. ("Masy" or "Masy BioServices"), a preferred provider of cGMP Biostorage and pharma support services.

Daily Times Chronicle
Dec 1st, 2021
Masy Systems Inc. launches SenseAnywhere modules

Masy BioServices announces the launch of innovative SenseAnywhere modules.